We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
KeyCorp
KEY
$24.4B
| $54.4M | 0.33% |
3,838,552
+32,589
| +0.9% | +$448K |
|
77
Essex Property Trust
ESS
$18.5B
| $53.6M | 0.33% |
233,354
+122,346
| +110% | +$27.7M |
|
78
iShares MSCI Emerging Markets ETF
EEM
$29.5B
| $51.6M | 0.32% |
1,285,467
-276,037
| -18% | -$11M |
|
|
EMC
79
DELISTED
EMC CORPORATION
EMC
| $51.1M | 0.31% |
1,998,423
+1,484,180
| +289% | +$40.9M |
|
80
HDFC Bank
HDB
$121B
| $50.4M | 0.31% |
3,422,380
-7,212,324
| -68% | -$105M |
|
81
Corning
GLW
$143B
| $48.4M | 0.3% |
2,133,676
+848,210
| +66% | +$20.2M |
|
82
FedEx
FDX
$75.4B
| $47.9M | 0.3% |
289,761
-134,776
| -32% | -$23.4M |
|
83
Colgate-Palmolive
CL
$74.4B
| $47.9M | 0.29% |
+690,372
| New | +$47.7M |
|
84
Ulta Beauty
ULTA
$24.3B
| $47.6M | 0.29% |
315,660
+189,775
| +151% | +$26.3M |
|
|
SAVE
85
DELISTED
Spirit Airlines, Inc.
SAVE
| $47.5M | 0.29% |
614,610
-6,466
| -1% | -$496K |
|
|
CAJ
86
DELISTED
Canon, Inc.
CAJ
| $47.2M | 0.29% |
1,333,736
+40,475
| +3% | +$1.32M |
|
87
ArcelorMittal
MT
$55.3B
| $45.2M | 0.28% |
2,099,817
+1,556,050
| +286% | +$36.5M |
|
88
Dollar Tree
DLTR
$25.2B
| $45M | 0.28% |
554,874
+528,228
| +1,982% | +$40.1M |
|
89
TJX Companies
TJX
$178B
| $44.5M | 0.27% |
1,269,766
+1,159,480
| +1,051% | +$39.5M |
|
90
F5
FFIV
$22.7B
| $44.3M | 0.27% |
385,316
+68,255
| +22% | +$8.03M |
|
|
HNT
91
DELISTED
HEALTH NET INC
HNT
| $44M | 0.27% |
726,971
-235,483
| -24% | -$13.3M |
|
92
CGI
GIB
$15.5B
| $43.9M | 0.27% |
1,035,564
+600,541
| +138% | +$24.6M |
|
93
Unum
UNM
$14.3B
| $43.4M | 0.27% |
1,285,945
+403,680
| +46% | +$13.4M |
|
94
Capital One
COF
$134B
| $42.5M | 0.26% |
539,474
-440,694
| -45% | -$34.6M |
|
|
LPNT
95
DELISTED
LifePoint Health, Inc.
LPNT
| $42.5M | 0.26% |
578,829
-61,760
| -10% | -$4.38M |
|
|
GRFS
96
Grifois
GRFS
$5.4B
| $42.4M | 0.26% |
2,586,002
+1,302,626
| +101% | +$21.8M |
|
97
Sanofi
SNY
$104B
| $41.6M | 0.26% |
840,849
-2,200,756
| -72% | -$105M |
|
98
NXP Semiconductors
NXPI
$60.4B
| $41.2M | 0.25% |
410,449
-169,370
| -29% | -$14.9M |
|
99
NVIDIA
NVDA
$5.42T
| $41.1M | 0.25% |
78,502,520
-8,428,240
| -10% | -$4.48M |
|
|
CVC
100
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $40.9M | 0.25% |
2,234,562
+871,033
| +64% | +$16.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.